Eli Lilly Beats on Earnings even as Weight Loss, Diabetes Drug Sales Fall Short

Eli Lilly Beats on Earnings even as Weight Loss, Diabetes Drug Sales Fall Short

Eli lilly on thuresday reported Mixed Results For the fourth Quarter, even as demand for its blockbuster weight loss and diabetes treatment mounjaro sorad. The company’s Quarterly Earnings Topped Wall Street Estimates, but sales fell just short as mounjaro saw lower realized pructions. Zepbound and mounjaro have no underperformed expectations for two straight qualiers, with … Read more

Eli Lilly Aims to Invest in ‘Big Problems Hidding In Plain Sight’ Using Obesity Windfall

Eli Lilly Aims to Invest in ‘Big Problems Hidding In Plain Sight’ Using Obesity Windfall

Heart disease. Hearing loss. Addiction. Chronic Pain. Alzheimer’s. Als. These are some of the areas where Eli lillyFlush with Cash from Its GLP-1 Drugs, Wants to Make Big Bets. These are the ideas that are “hidding in plain sight,” said lilly Chief SCINITIC Officer Dan Skovronsky. They’re places where other pharmaceutical companies might not want … Read more

East Germany is a Far-Right Strongold-and Economic Concerns Helped Make It Happen

East Germany is a Far-Right Strongold-and Economic Concerns Helped Make It Happen

Alice Weidel, Chancellor Candidate of the Far-Right Alternative for Germany (AFD) Political Party, Speaks to Supporters as They Wave German Flags at the AFD Election CampaaiGN LAUNCHN LAUNCHN LAUNCHN RALYLY. Sean Gallup | Getty Images News | Getty Images Germany’s far-right party is dominating polls in the country’s Eastern Region Less Than Two Weeks Before … Read more

Doximity Shares Soar 25% After Company Beats on Revenue, Raises Fiscal-Year Guidance

Doximity Shares Soar 25% After Company Beats on Revenue, Raises Fiscal-Year Guidance

Doximity at the New York Stock Exchange for Its Initial Public Offering on June 24, 2021. Source: Nyse Shares of Doximity Popped 25% in Extended Trading on CHURSDAY After The Company Reported Third -Quarter Fiscal 2025 Results that Beat Analysts’ Expectations for Revenue and Offred Rosy Guidance. Here’s how the company did: Earnings per share: … Read more

Doximity Shares Pop 36% on Revenue Beat, Rosy Guidance

Doximity Shares Pop 36% on Revenue Beat, Rosy Guidance

Piotr Swat | Lightrocket | Getty Images Doximity Shares Closed up 36% on Friday, a day after the company reported Fiscal Third-Quarter Results That Beat Wall Street’s Expectations for Revenue and Guidance. Doximity is a digital platform for medical professionals that can help them carry out telehealth appointments with patients, find referrals, stock referrals, stock … Read more

Dominari Holdings Shares SURGE 30% After Donald Trump Jr. And Eric Trump Join Advisory Board

Dominari Holdings Shares SURGE 30% After Donald Trump Jr. And Eric Trump Join Advisory Board

Eric Trump during an interview with the pa news agency at Trump International Golf Links Near Balmedie, Aberdeenshire. Jane Barlow – Pa Images | Pa Images | Getty Images Dominari holdings Shares Shot up Tuesday after the Holding Company Announced that President Donald Trump‘S Sons – Donald Trump Jr. And Eric Trump – Have Joined … Read more

Deepseek has rattled large ai players – but smaller chip firms see it as a force multiplier

Deepseek has rattled large ai players – but smaller chip firms see it as a force multiplier

Deepseek has rattled the US-LED AI Ecosystem with its latest model, shaving hundreds of billions in chip leader Nvidia’s Market Cap. While the sector leaders grapple with the fallout, smaller ai companies Several AI-Related Firms Told CNBC that Deepsek’s Emergence is a “Massive” Oportunity for Them, Rather than a Threat. “Developers are very keen to … Read more

CVS CEO Defends Pharmacy Middlemen, Accuses Drugmakers of ‘Monopolistic’ practices

CVS CEO Defends Pharmacy Middlemen, Accuses Drugmakers of ‘Monopolistic’ practices

David joyner, a longtime cvs executive, Speaks during a Senate Health, Education, Labor and Pensions Committee Hearing in Washington, DC, on May 10, 2023. Al Drago | Bloomberg | Getty Images Cvs health Ceo David Joyner on Wednsday Defended Controversial pharmacy middlemen Like his company’s caremark unit, which is widely accuced of inflating prescription medication … Read more